COMMUNIQUÉS West-GlobeNewswire

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes
15/05/2025
Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes The Paediatric Committee (PDCO) of the European Medicines Agency issues positive opinion on PolTREG’s Pediatric [...]
Aino Health AB (publ): interim report january-march 2025
15/05/2025
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Increased turnover. Positive cashflow. Positive EBITDA. January – March 2024 Turnover [...]
AB Science today reports a new publication in the scientific journal PLOS One, showing promising neuroprotective effects of masitinib
15/05/2025
PRESS RELEASE MASITINIB SHOWS PROMISING NEUROPROTECTIVE EFFECTS IN NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE MODEL A NEW PUBLICATION IN THE SCIENTIFIC JOURNAL PLOS ONE, SHOWS THAT MASITINIB CAN LOWER SERUM [...]
AB Science annonce aujourd'hui une nouvelle publication dans la revue scientifique PLOS One, montrant l’effet neuroprotecteur prometteur du masitinib
15/05/2025
COMMUNIQUÉ DE PRESSE LE MASITINIB MONTRE DES EFFETS NEUROPROTECTEURS PROMETTEURS DANS UN MODÈLE DE MALADIE NEURODÉGÉNÉRATIVE INDUITE PAR LE SYSTÈME IMMUNITAIRE UNE NOUVELLE PUBLICATION DANS LA REVUE SCIENTIFIQUE PLOS [...]
CROSSJECT’s ZENEO® needle-free autoinjector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors
15/05/2025
Press Release CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection depth [...]
L'auto-injecteur sans aiguille ZENEO® de CROSSJECT est conforme aux profondeurs des injections intramusculaires traditionnelles et surpasse les longueurs des aiguilles des auto-injecteurs actuels
15/05/2025
Communiqué de Presse L'auto-injecteur sans aiguille ZENEO® de CROSSJECT est conforme aux profondeurs des injections intramusculaires traditionnelles et surpasse les longueurs des aiguilles des auto-injecteurs actuels La [...]
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
15/05/2025
Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration BRUSSELS, May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) [...]
Best Delta 8 Gummies For Euphoria by Candy Cloud in 2025
15/05/2025
LOS ANGELES, May 15, 2025 (GLOBE NEWSWIRE) -- Search interest for Delta-8 THC has grown over 800% since 2020, and gummies dominate those queries. According to Google Trends and retail data, gummies now outpace [...]
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
15/05/2025
KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today [...]
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
15/05/2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug [...]
NovaaLab Under Review: Best At-Home Red Light Therapy Products for Healing Pain & Recovery Support
15/05/2025
Explore NovaaLab’s FDA-cleared red light therapy devices, supported by clinical studies, and designed to help reduce pain, improve recovery, and support wellness — all from the comfort of home. Salt Lake City, May 14, [...]
Audien Atom Hearing Aid Under Review: The Audien Pro & Atom One OTC Hearing Devices for Crystal Clear Sound
15/05/2025
Exploring how Audien's OTC hearing aids—Atom One and Pro 2—are transforming hearing accessibility with invisible designs, crystal clear sound, and prescription-free convenience for adults with mild to moderate hearing [...]
Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results
14/05/2025
CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced [...]
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
14/05/2025
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption (IDE) [...]
Precipio Announces its Q1-2025 Financial Results
14/05/2025
Conference call to follow tomorrow, May 15 at 5 PM EST NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , filed its 10-Q report today. The following [...]
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
14/05/2025
Correction: Time of BofA Conference SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that [...]
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
14/05/2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General and Special Meeting of [...]
SS Innovations Reports First Quarter 2025 Financial Results
14/05/2025
Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- SS [...]
Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report
14/05/2025
NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact Report today, which covers the company’s approach to corporate responsibility. The report [...]

Pages